In conclusion, we hypothesize the enhancement of the normal diagnostic iter for prostate cancer, proposing an easy-to-perform test that can integrate the use of PSA test more economically than magnetic resonance imaging and less invasively than prostate biopsies. The gene discussed is KLK3; the disease is prostate cancer.